Latest Insider Transactions at Tg Therapeutics, Inc. (TGTX)
This section provides a real-time view of insider transactions for Tg Therapeutics, Inc. (TGTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TG THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TG THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Sagar Lonial Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+19.05%
|
-
|
|
Jun 18
2021
|
Michael S Weiss CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,080,770
+7.1%
|
-
|
|
Jun 18
2021
|
Sean A Power CFO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+3.68%
|
-
|
|
Dec 30
2020
|
Sean A Power CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+2.97%
|
-
|
|
Dec 10
2020
|
Yann Echelard Director |
SELL
Open market or private sale
|
Direct |
30,000
-18.85%
|
$1,200,000
$40.05 P/Share
|
|
Sep 09
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
158,589
-1.24%
|
$3,964,725
$25.81 P/Share
|